Share this article on:

Adalimumab Sustains Deep Remission for 3 Years: Data From CHARM and ADHERE: P-58

Sandborn, William1; Colombel, Jean-Frédéric2; Louis, Edouard3; Panaccione, Remo4; Yang, Mei5; Chao, Jingdong5; Thakkar, Roopal5; Robinson, Anne5; Pollack, Paul5; Mulani, Parvez5

Inflammatory Bowel Diseases: December 2012 - Volume 18 - Issue - p S39
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13–15, 2012 Hollywood, Florida: Clinical Poster Presentations